Arbutus Biopharma Corp Financial Ratios — ABUS Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-126.54	128.4	-28.09	-52.76	-19.73	-102.35	-50.83	-64.95	- -	- -	- -	-45.35	-59.99	-68.76	-38.52
Return on Assets (%)	-58.08	89.33	-22.63	-40.9	-15.1	-77.75	-32.9	-24.54	-92.2	-52.55	-44.65	-34.74	-42.88	-50.65	-29.6
Return on Capital (%)	- -	128.4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	144.46	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	-15.93	-27.92	-38.75	-158.9	-121.28	-4,008.18	-485.76	-874.5	-858.26	-586.74	100	100	100	100	100
EBITDA Margin (%)	-57.74	242.35	-74.61	-216.97	-234.86	-6,653.25	-636.5	-1,143.67	-1,153.17	-799.7	-636.12	-158.37	-422.41	-1,111.55	-189.51
Operating Margin (%)	-63.61	236.21	-78.58	-220.5	-237.39	-6,726.49	-655.44	-1,180.35	-1,186.91	-828.3	-652.07	-162.03	-430.15	-1,133.92	-192.08
Incremental Operating Margin (%)	- -	-1,626.06	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-59.98	209.93	-90.93	-259.73	-338.99	-32,807.91	-1,016.2	-1,031.83	-2,767.91	-921.97	-693.91	-166.62	-401.57	-1,133.04	-237.88
Profit Margin (%)	-59.98	209.93	-90.93	-259.73	-269.45	-25,765.53	-788.91	-959.8	-2,557.36	-921.97	-693.91	-178.01	-401.57	-1,133.04	-237.88
Net Income to Common Margin (%)	-59.98	209.93	-90.93	-259.73	-269.45	-25,765.53	-797.42	-1,129.54	-2,742.84	-921.97	-693.91	-178.01	-401.57	-1,133.04	-237.88
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	1.07	15.03	6.76	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-126.54	128.4	-28.09	-52.76	-19.73	-102.35	-50.29	-55.19	- -	- -	- -	-45.35	-59.99	-68.76	-38.52

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	12	12	- -	3	3	3	2	2	1	1
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
LT Debt	- -	- -	- -	- -	- -	12	12	- -	3	3	2	2	1	1	- -
Total Debt/EBITDA	- -	- -	- -	- -	- -	-0.12	-0.18	- -	-0.05	-0.05	-0.04	-0.04	-0.02	-0.02	-0.03
Net Debt/EBITDA	0.93	-1.38	5.96	2.23	3.05	0.12	0.62	0.54	0.46	0.95	1.56	0.5	0.34	0.53	0.67
Total Debt/EBIT	- -	- -	- -	- -	- -	-0.12	-0.17	- -	-0.05	-0.05	-0.04	-0.03	-0.02	-0.02	-0.03
Net Debt/EBIT	0.84	-1.41	5.65	2.19	3.02	0.11	0.6	0.53	0.45	0.91	1.53	0.49	0.34	0.52	0.67
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	-260.94	-300.85	-32.88	-13.78	-24.47	-35.8	-166.95	-500.69	-275.13
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	-288.77	-305.88	-33.16	-13.84	-24.75	-36.1	-169.15	-502.01	-275.13
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	-268.7	-310.5	-33.84	-14.28	-25.08	-36.63	-170.01	-510.76	-278.88
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	2	4	3	2	- -	- -	- -
Common Equity/Total Assets	37.99	77.8	82.54	74.49	76.89	73.57	55.95	32.51	-61.16	-34.61	82.86	70.03	73.42	73.93	80.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	5.91	6.58	- -	4.15	2.54	1.32	1.33	1.27	0.83	0.26
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	5.58	6.17	- -	3.97	2.47	1.3	1.31	1.25	0.82	0.26
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.35	5.06	- -	2.86	1.89	1.09	0.93	0.93	0.61	0.21
Total Debt/Equity (%)	- -	- -	- -	- -	- -	5.91	6.58	- -	4.62	2.93	1.54	1.6	1.67	1.32	0.97
Total Debt/Capital (%)	- -	- -	- -	- -	- -	5.58	6.17	- -	4.41	2.84	1.52	1.57	1.64	1.31	0.96
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.35	5.06	- -	3.18	2.18	1.28	1.12	1.22	0.98	0.79
Net Debt to Equity	-172.79	-114.92	-116.09	-82	-30.45	-5.62	-23.18	-18.45	-43.71	-51.24	-64.5	-22.49	-24.79	-37.31	-23.52
Net Debt/Capital (%)	237.39	770.21	721.59	-455.5	-43.79	-5.96	-30.17	-22.62	-71.78	-99.15	-174.1	-28.43	-32.25	-58.29	-30.36
EBITDA	-10	34	-12	-32	-55	-99	-68	-68	-69	-55	-70	-62	-77	-69	-27
EBITDA-CapEx	-10	34	-12	-33	-57	-103	-75	-69	-70	-56	-71	-62	-78	-69	-27
Operating Income (Loss)	-11	33	-12	-33	-55	-100	-70	-70	-71	-57	-72	-63	-78	-70	-27

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.31	4.29	5.49	5.55	17.14	12.33	8.64	11.09	11.6	12.92	13.84	4.47	5.6	7.85	15.23
Current Ratio	1.69	4.68	5.62	5.76	17.38	12.52	8.84	11.5	11.99	13.38	14.32	4.6	5.87	8.15	15.73
Quick Ratio	1.51	4.61	5.52	5.68	17.27	12.4	8.7	11.22	11.76	13.06	13.92	4.51	5.68	8.01	15.47
CFO/Avg Current Liab	-1.05	3.7	-0.57	-0.76	-3.66	-5.47	-3.86	-5.25	-7.45	-5.92	-6.51	-1.6	-3.11	-3.4	-3.67
Common Equity/Total Assets	37.99	77.8	82.54	74.49	76.89	73.57	55.95	32.51	-61.16	-34.61	82.86	70.03	73.42	73.93	80.93
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	5.91	6.58	- -	4.15	2.54	1.32	1.33	1.27	0.83	0.26
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	5.58	6.17	- -	3.97	2.47	1.3	1.31	1.25	0.82	0.26
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.35	5.06	- -	2.86	1.89	1.09	0.93	0.93	0.61	0.21
Total Debt/Equity (%)	- -	- -	- -	- -	- -	5.91	6.58	- -	4.62	2.93	1.54	1.6	1.67	1.32	0.97
Total Debt/Capital (%)	- -	- -	- -	- -	- -	5.58	6.17	- -	4.41	2.84	1.52	1.57	1.64	1.31	0.96
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	4.35	5.06	- -	3.18	2.18	1.28	1.12	1.22	0.98	0.79
CFO/Total Liabilities	-92.16	281.83	-53.8	-41.21	-34.25	-79.39	-88.94	-245.26	-216.54	-146.5	-192.7	-60.37	-223.89	-188.84	-219.69
CFO/CapEx	-129.7	2,193.87	-9.29	-11.76	-24.65	-14.49	-6.7	-59.64	-120.55	-224.63	-83.48	-69.05	-85.25	-356.32	- -
Altman's Z-Score	-25.55	2.85	4.64	4.51	-0.76	-6.11	-4.19	-2.79	-10.77	-5.47	1.66	-5.01	-6.49	-4.15	10.7

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	8.04	14.56	25.95	14.8	15.99	2.33	31.7	6.49	4.56	5.5	9.94	34.67	11.6	2.95	7.3
Days Sales Outstanding	45.38	25.07	14.07	24.65	22.82	156.8	11.51	56.27	80	66.41	36.72	10.53	31.47	123.77	49.97
Inventory Turnover	258.64	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	1.41	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	30.74	17.48	21.22	23.74	22.13	21.03	24.1	22.37	20.61	17.61	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	11.87	20.88	17.2	15.37	16.49	17.36	15.15	16.31	17.71	20.72	- -	- -	- -	- -	- -
Cash Conversion Cycle	34.92	4.19	-3.14	9.28	6.33	139.44	-3.63	39.95	62.29	45.69	- -	- -	- -	- -	- -
Inventory to Cash Days	43.97	25.07	14.07	24.65	22.82	156.8	11.51	56.27	80	66.41	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	18	71	152	340	243	134	278	217	180	322	564	367	425	621	926
- Cash & Cash Equivalents	9	47	69	72	167	23	54	37	32	52	109	31	26	36	18
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	50	126	137	149	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	12	12	- -	3	3	3	2	2	1	1
Enterprise Value	9	24	83	228	62	16	213	219	230	352	411	222	300	500	835
Total Capital	5	41	59	88	548	215	194	200	76	105	172	139	108	99	77
Total Debt/Capital (%)	- -	- -	- -	- -	- -	5.58	6.17	- -	4.41	2.84	1.52	1.57	1.64	1.31	0.96
Total Debt / EV	- -	- -	- -	- -	- -	0.76	0.06	- -	0.01	0.01	0.01	0.01	0.01	- -	- -
EV/Sales	0.55	1.7	5.37	15.23	2.64	10.6	19.95	36.77	38.25	50.86	37.43	5.69	16.56	81	59.32
EV/EBITDA	- -	0.7	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	0.72	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	0.73	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	0.73	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	17	71	122	340	202	130	273	212	159	269	413	352	415	607	922
Diluted Enterprise Value	8	24	53	268	36	119	281	301	268	369	307	323	390	572	904
EV per Share	0.76	1.67	4.36	10.15	1.13	0.29	3.88	3.86	3.55	3.87	2.84	1.41	1.77	2.63	4.34
TTM Sales	17	14	15	15	23	1	11	6	6	7	11	39	18	6	14
TTM EBITDA	-10	34	-12	-32	-55	-99	-68	-68	-69	-55	-70	-62	-77	-69	-27
TTM Operating Income	-11	33	-12	-33	-55	-100	-70	-70	-71	-57	-72	-63	-78	-70	-27
TTM Cash Flow to Firm	-8	33	-7	-12	-56	-58	-48	-68	-69	-47	-65	-34	-85	-65	-40
TTM Free Cash Flow to Firm	-8	33	-6	-11	-54	-54	-41	-67	-68	-47	-64	-33	-84	-65	-40

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-2.18	2.16	-20.29	-29.91	-3.74	-2.41	-6.6	-3.17	-2.25	-5.26	-6.19	-10.09	-4.89	-9.39	-23.25
EV/EBIT	- -	0.72	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	9	24	83	228	62	16	213	219	230	352	411	222	300	500	835
Low Price	1.29	1.52	4.18	7.65	4.25	2.35	2.35	3.2	0.82	0.88	2.43	1.85	1.69	2.21	2.71
EV/Sales	0.55	1.7	5.37	15.23	2.64	10.6	19.95	36.77	38.25	50.86	37.43	5.69	16.56	81	59.32
EV/EBITDA	- -	0.7	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	2.3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-3.29	1.42	-6.36	-9.49	-8.99	-0.51	-2.6	-5.38	-0.84	-3.24	-4.93	-5.63	-5.39	-8.72	-21.25
Price/Earnings High	-8.91	3.14	-12.43	-18.19	-19.38	-0.76	-5.23	-10.38	-1.64	-10.73	-9.06	-8.71	-7.18	-12.53	-29.17
Price/Earnings Low	-1.45	0.7	-4.55	-4.42	-3.08	-0.32	-1.49	-2.64	-0.28	-1.05	-3.39	-4.02	-3.85	-5.87	-15.5
Price/Book Value	3.5	1.73	2.56	3.86	0.44	0.66	2.1	2.93	-2.79	-6.8	3.33	2.68	4.01	6.38	12.09
Price/Book Value Average	6.85	1.07	1.88	4.19	1.24	0.99	1.7	5	-2.43	-5.22	3.03	2.98	3.79	6.41	9.34
Price/Book Value High	18.53	2.37	3.68	8.02	2.66	1.48	3.42	9.64	-4.77	-17.27	5.56	4.61	5.05	9.21	12.82
Price/Book Value Low	3.01	0.53	1.35	1.95	0.42	0.63	0.98	2.45	-0.82	-1.69	2.08	2.13	2.71	4.31	6.81
Price/Tangible Book Value	3.5	1.73	2.56	3.86	7.47	1.7	5.6	27.86	-2.79	-6.8	3.33	2.68	4.01	6.38	12.09
Price/Tangible Book Value Average	6.85	1.07	1.88	4.19	20.82	2.53	4.54	47.53	-2.43	-5.22	3.03	2.98	3.79	6.41	9.34
Price/Tangible Book Value High	18.53	2.37	3.68	8.02	44.85	3.79	9.14	91.67	-4.77	-17.27	5.56	4.61	5.05	9.21	12.82
Price/Tangible Book Value Low	3.01	0.53	1.35	1.95	7.13	1.63	2.6	23.28	-0.82	-1.69	2.08	2.13	2.71	4.31	6.81
Price/Sales	1.01	4.83	7.89	22.73	8.69	87.18	25.53	35.63	26.4	38.94	37.61	9.01	22.87	98.35	65.44
Price/Sales Average	1.98	2.98	5.78	24.65	24.23	130.21	20.7	60.77	22.96	29.89	34.24	10.02	21.65	98.81	50.55
Price/Sales High	5.35	6.6	11.3	47.24	52.21	194.99	41.71	117.21	45.12	98.93	62.85	15.51	28.82	141.97	69.39
Price/Sales Low	0.87	1.48	4.14	11.48	8.3	83.62	11.88	29.77	7.79	9.65	23.5	7.16	15.46	66.47	36.87
Price/Cash Flow	-2.17	2.07	-18.1	-27.37	-3.59	-2.25	-5.62	-3.12	-2.24	-5.23	-6.12	-9.95	-4.83	-9.36	-23.25
Price/Cash Flow Average	-4.24	1.28	-13.27	-29.67	-10	-3.35	-4.55	-5.32	-1.94	-4.02	-5.57	-11.05	-4.57	-9.4	-17.96
Price/Cash Flow High	-11.48	2.83	-25.94	-56.87	-21.55	-5.02	-9.18	-10.27	-3.82	-13.3	-10.23	-17.12	-6.08	-13.51	-24.65
Price/Cash Flow Low	-1.86	0.63	-9.49	-13.82	-3.43	-2.15	-2.61	-2.61	-0.66	-1.3	-3.82	-7.9	-3.26	-6.33	-13.1
Price/Free Cash Flow Average	-4.28	1.33	-14.87	-32.43	-10.43	-3.6	-5.35	-5.41	-1.96	-4.04	-5.64	-11.22	-4.63	-9.43	-17.96
Price/Free Cash Flow High	-11.57	2.95	-29.07	-62.15	-22.46	-5.39	-10.79	-10.44	-3.85	-13.36	-10.35	-17.37	-6.16	-13.55	-24.65
Price/Free Cash Flow Low	-1.88	0.66	-10.64	-15.1	-3.57	-2.31	-3.07	-2.65	-0.66	-1.3	-3.87	-8.01	-3.3	-6.34	-13.1
EV/Sales Average	1.59	- -	2.75	19.82	21.92	126.95	21.76	77.29	44.16	50.29	37.02	9.71	20.81	95.45	49.57
EV/Sales High	5.2	3.54	9.62	42.41	55.5	193.91	43.15	135.14	69.3	133	76.06	15.45	28.14	139.62	68.5
EV/Sales Low	0.4	- -	0.71	6.65	2.8	78.78	12.79	45.51	26.94	26.05	22.36	6.73	14.47	62.35	35.82
EV/EBITDA Average	-2.75	-0.09	-3.69	-9.13	-9.33	-1.91	-3.42	-6.76	-3.83	-6.29	-5.82	-6.13	-4.93	-8.59	-26.16
EV/EBITDA High	-9.01	1.46	-12.9	-19.55	-23.63	-2.91	-6.78	-11.82	-6.01	-16.63	-11.96	-9.75	-6.66	-12.56	-36.15
EV/EBITDA Low	-0.69	-0.74	-0.95	-3.07	-1.19	-1.18	-2.01	-3.98	-2.34	-3.26	-3.51	-4.25	-3.43	-5.61	-18.9
EV/EBIT Average	-2.49	-0.09	-3.5	-8.99	-9.23	-1.89	-3.32	-6.55	-3.72	-6.07	-5.68	-6	-4.84	-8.42	-25.8
EV/EBIT High	-8.18	1.5	-12.25	-19.23	-23.38	-2.88	-6.58	-11.45	-5.84	-16.06	-11.66	-9.53	-6.54	-12.31	-35.66
EV/EBIT Low	-0.62	-0.76	-0.9	-3.02	-1.18	-1.17	-1.95	-3.86	-2.27	-3.14	-3.43	-4.16	-3.36	-5.5	-18.65
Last Price	1.5	4.96	7.97	15.15	4.45	2.45	5.05	3.83	2.78	3.55	3.89	2.33	2.5	3.27	4.81
High Price	7.94	6.78	11.42	31.48	26.73	5.48	8.25	12.6	4.75	9.02	6.5	4.01	3.15	4.72	5.1
Enterprise Value Average	27	-3	43	296	510	189	233	460	265	348	407	379	378	589	698
Enterprise Value High	87	50	149	634	1,292	289	462	803	417	920	836	603	511	862	965
Enterprise Value Low	7	-25	11	99	65	117	137	271	162	180	246	263	263	385	504

Shares Outstanding	12	14	19	22	55	55	55	57	65	91	145	157	170	190	193
Diluted Weighted Avg Shares	11	14	15	22	45	53	54	55	57	76	106	151	166	186	192
Basic Weighted Avg Shares	11	14	15	22	45	53	54	55	57	76	106	151	166	186	192
Revenue per Share	1.49	1.03	1.01	0.67	0.51	0.03	0.2	0.11	0.11	0.09	0.1	0.26	0.11	0.03	0.07
EBITDA per Share	-0.86	2.49	-0.75	-1.45	-1.2	-1.87	-1.26	-1.23	-1.21	-0.73	-0.66	-0.41	-0.46	-0.37	-0.14
Operating Income per Share	-0.94	2.43	-0.79	-1.47	-1.22	-1.89	-1.3	-1.27	-1.25	-0.76	-0.67	-0.42	-0.47	-0.38	-0.14
Basic EPS, GAAP	-0.89	2.16	-0.92	-1.73	-1.38	-7.24	-1.58	-1.21	-2.89	-0.84	-0.72	-0.46	-0.44	-0.38	-0.17
Basic EPS from Cont Ops	-0.89	2.16	-0.92	-1.73	-1.38	-7.24	-1.56	-1.03	-2.69	-0.84	-0.72	-0.46	-0.44	-0.38	-0.17
Diluted EPS, GAAP	-0.89	2.07	-0.92	-1.73	-1.38	-7.24	-1.58	-1.21	-2.89	-0.84	-0.72	-0.46	-0.44	-0.38	-0.17
Diluted EPS from Cont Ops	-0.89	2.07	-0.92	-1.73	-1.38	-7.24	-1.56	-1.03	-2.69	-0.84	-0.72	-0.46	-0.44	-0.38	-0.17
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.69	2.4	-0.44	-0.55	-1.24	-1.09	-0.9	-1.23	-1.24	-0.68	-0.64	-0.23	-0.52	-0.35	-0.21
Free Cash Flow per Basic Share	-0.7	2.4	-0.49	-0.6	-1.29	-1.17	-1.03	-1.25	-1.25	-0.68	-0.64	-0.24	-0.52	-0.35	-0.21
Cash & Equivalents per Share	0.74	3.29	3.61	5	3.32	2.38	2.29	2.2	1.4	1.36	1.07	0.93	0.74	0.65	0.48
Book Value per Share	0.43	2.86	3.11	3.92	10.04	3.7	2.41	1.31	-1	-0.52	1.17	0.87	0.62	0.51	0.4
Tangible Book Value per Share	0.43	2.86	3.11	3.92	0.6	1.44	0.9	0.14	-1	-0.52	1.17	0.87	0.62	0.51	0.4

Arbutus Biopharma Corp

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)